Found: 10
Select item for more details and to access through your institution.
Hypertension does not alter disturbances in leptin signalling observed in experimental model of tauopathy.
- Published in:
- General Physiology & Biophysics, 2021, v. 40, n. 6, p. 577, doi. 10.4149/gpb_2021037
- By:
- Publication type:
- Article
P3-333: A novel tau conformation in Alzheimer’s disease revealed by antibody DC11
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-333: A novel tau conformation in Alzheimer’s disease revealed by antibody DC11
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03060-4
- By:
- Publication type:
- Article
Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.
- Published in:
- Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0770-y
- By:
- Publication type:
- Article
A Novel RP-UHPLC-MS/MS Approach for the Determination of Tryptophan Metabolites Derivatized with 2-Bromo-4′-Nitroacetophenone.
- Published in:
- Biomedicines, 2024, v. 12, n. 5, p. 1003, doi. 10.3390/biomedicines12051003
- By:
- Publication type:
- Article
Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 51, doi. 10.3390/antib12030051
- By:
- Publication type:
- Article
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0436-1
- By:
- Publication type:
- Article
Plasma Leptin Reflects Progression of Neurofibrillary Pathology in Animal Model of Tauopathy.
- Published in:
- Cellular & Molecular Neurobiology, 2022, v. 42, n. 1, p. 125, doi. 10.1007/s10571-020-00972-6
- By:
- Publication type:
- Article
Truncated tau from sporadic Alzheimer’s disease suffices to drive neurofibrillary degeneration in vivo
- Published in:
- FEBS Letters, 2006, v. 580, n. 15, p. 3582, doi. 10.1016/j.febslet.2006.05.029
- By:
- Publication type:
- Article